News From Around the System

Immune Cells Leave Fingerprints on Tumors Metastasized to the Brain, Offering Clues to Future Therapies

UCSF Health — February 7, 2022

Using data from over 100,000 malignant and non-malignant cells from 15 human brain metastases, UCSF researchers have revealed two functional archetypes of metastatic cells across 7 different types of brain tumors, each containing both immune and non-immune cell types.

High blood pressure linked to working longer hours

UCLA Health — February 7, 2022

Research has shown that people who put in long work hours can be at higher risk of developing high blood pressure than those who work shorter hours

How to do an at-home COVID-19 rapid antigen test correctly

UC Davis Health — February 7, 2022

At-home rapid antigen tests are a key tool in stopping the spread of COVID-19, but it’s important they are used properly. UC Davis Health pediatric nurse Claudio Alvarado shares a step-by-step guide to doing a test.

two orange ihealh COVID test kit boxes on a countertop with three vials of liquid and testing instructions

How to celebrate the Super Bowl safely

UCLA Health — February 6, 2022

COVID-19 transmission rates remain high, but masks, vaccination and physical distancing continue to reduce risk.

Former faculty member gives UCLA $10 million to advance ocular genetics research

UCLA Health — February 6, 2022

A gift from Dr. Bronwyn Bateman will establish a new center at the UCLA Stein Eye Institute.

Sweating the small stuff: Smartwatch developed at UCLA measures key stress hormone

UCLA Health — February 6, 2022

The device assesses cortisol levels found in sweat accurately, noninvasively and in real time.

UCLA experts discuss women’s heart health and managing risk factors

UCLA Health — February 4, 2022

Heart disease is the leading cause of death in the U.S. for men and women.

Sorting out the varieties of COVID-19 masks

UCLA Health — February 4, 2022

The type of mask you wear determines the level of protection for you and others

UC Davis becomes first in region to grow cancer-fighting CAR T cells

UC Davis Health — February 4, 2022

On World Cancer Day, UC Davis Health announced it has successfully treated its first patient with super-charged cancer-fighting cells genetically modified in its cellular therapy lab. UC Davis is the first University of California medical center to make the re-engineered CAR T cells on site.